2024. AN OBSERVATIONAL STUDY TO EVALUATE THE POSTVACCINATION SYMPTOMS (COVAXIN) IN GENERAL POPULATION MORE THAN 18 YEARS OF AGE. CAHIERS MAGELLANES-NS. 6, 2 (Jul. 2024), 720–731.